Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study.
about
Allergen-specific immunotherapy in pediatric allergic asthmaRecombinant allergens: the present and the futureRole of immunotherapy in the treatment of allergic asthmaImmunological mechanisms of allergen-specific immunotherapyInternational consensus on (ICON) pediatric asthmaDifferential Plasma-cell evolution is linked with Dermatophagoides pteronyssinus immunotherapy response.Sublingual immunotherapy in children with allergic rhinitis: quality of systematic reviews.Randomized double-blind placebo-controlled trial of sublingual immunotherapy in children with house dust mite allergy in primary care: study design and recruitment.Changes in skin reactivity and associated factors in patients sensitized to house dust mites after 1 year of allergen-specific immunotherapy.Current specific immunotherapy for allergic rhinitis: perspectives from otorhinolaryngologistsRecombinant house dust mite allergens.Allergen immunotherapy for house dust mite: clinical efficacy and immunological mechanisms in allergic rhinitis and asthma.Patients' compliance with different administration routes for allergen immunotherapy in Germany.Immunotherapy for house dust mite sensitivity: where are the knowledge gaps?Differential regulation of IL-4Ralpha expression by antigen versus cytokine stimulation characterizes Th2 progression in vivoTreating the allergic patient: think globally, treat globally.The need for patient-focused therapy for children and teenagers with allergic rhinitis: a case-based review of current European practiceImmunotherapy reduces allergen-mediated CD66b expression and myeloperoxidase levels on human neutrophils from allergic patients.Intralymphatic immunotherapyActual therapeutic management of allergic and hyperreactive nasal disordersProspective adherence to specific immunotherapy in Europe (PASTE) survey protocol.New targets for allergic rhinitis--a disease of civilization.Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical AssoTregs and allergic diseaseTolerizing allergic responses in the lung.In search for predictive factors for atopy in human cord blood.Sublingual immunotherapy for allergic rhinoconjunctivitis--the seeming and the real.Efficacy of allergen immunotherapy in reducing the likelihood of developing new allergen sensitizations: a systematic review.Summary of recommendations from the Canadian Asthma Consensus guidelines, 2003.Subcutaneous Immunotherapy Improves the Symptomatology of Allergic Rhinitis.Allergen immunotherapy in allergic respiratory diseases: from mechanisms to meta-analysesMechanisms of allergen specific immunotherapy--T-cell tolerance and more.Sublingual immunotherapy in the treatment of children.Future developments in sublingual immunotherapy.Sublingual immunotherapy of allergic diseases.Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction.House dust allergy and immunotherapy.New routes for allergen immunotherapy.Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial.Perennial is more effective than preseasonal subcutaneous immunotherapy in the treatment of seasonal allergic rhinoconjunctivitis
P2860
Q26739254-CC866AA2-F392-42CC-8467-AD55974A529CQ26996701-13C09B57-FDF0-4D23-8AC5-563C832D1D3FQ27021489-51AA76B6-8E7F-4BFF-A66A-A185986751D7Q28265326-1EC07BE4-8CEE-4F9D-9631-D5D5551F2843Q30393965-C19BA56E-B4DE-4CAE-B608-2F024F6C84B0Q30402227-6967C64B-0674-47EA-ACAD-CDAB83D6C446Q31030974-6F539C08-2F41-4A2A-907B-3AFE02B2D4C6Q33378244-20B2C685-1C33-432C-BF4F-CFAEB4A1A194Q33619064-060AD643-B291-4940-AF33-EF678415223FQ33831562-0853D14F-27E7-4D50-8932-C13FCFF4BCF3Q34361546-18E23E2A-FFFE-479E-AEDD-473EB11FDC18Q34375745-1D023D86-7340-4E54-BDB3-57D12F882D96Q34434850-7693A205-A601-4AB7-A9D4-350A647077F8Q34445398-CAC3688B-AA9C-48F5-86F9-2E83BD7E604AQ34732223-4724F03C-ACB8-49EC-B3C2-6129EA975B34Q34881155-A2071681-D7FD-4C72-AD3A-FAA268CCCC06Q35052674-0301F533-8B3C-4848-80B1-B9458EC6881BQ35150494-A624086B-CD4A-41F7-B89A-E49E8A2FF3F4Q35155423-F5C60716-174E-4460-B525-7465BD9DDB00Q35427205-69AAAF54-8F4D-4630-8739-2BB6A50CBF78Q35540640-FE146723-C52B-4C8C-AF0B-20916446F1CCQ35605442-60E2DA42-BD53-4635-B62B-B219C456DAFBQ35777126-95673778-2713-4BCC-B399-0DFDB06C19AFQ35951537-966D584E-BE7F-416F-A434-D22440694773Q36054136-FDCCC19D-38F5-4658-9586-A32E947F03DAQ36117559-1C311AF8-15E9-4C40-BCA4-B33C6FD75CCBQ36157889-C9E2CE23-3CBC-4BEB-8401-150BA91B0A01Q36215069-795719FE-E3B0-4893-8EAE-113E6CD441A1Q36255673-1058F147-D50D-45DC-8155-0872FCA17D97Q36395399-D5468535-DA39-48B3-9F73-F921B9C8C87AQ36411170-D933A1DB-4639-4B78-8371-3100D8E5C649Q36515366-22508432-07BA-4E79-875C-E00066E2089BQ36515380-0AAD64D0-C0DF-496C-A219-7EBD16E25DDBQ36515402-7EE04C50-CA78-4321-8F95-E23D76E9EDCAQ36583727-98A23BA1-D96A-4B1B-A777-5C6D139C7C70Q36826600-80FE07B5-5A11-4432-A10D-37930E376DF1Q36863569-788C6C15-BE08-4A21-B529-AE045DA5524CQ36864957-6CA18671-EBDF-4C2D-A633-FD8A918B036AQ36970017-7ED32C60-EB61-401B-8CB5-E039B6A324F7Q37013813-5C5CE7D1-7C7C-4211-8446-E7F85FAA47F7
P2860
Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Prevention of new sensitizatio ...... y. A six-year follow-up study.
@en
Prevention of new sensitizatio ...... y. A six-year follow-up study.
@nl
type
label
Prevention of new sensitizatio ...... y. A six-year follow-up study.
@en
Prevention of new sensitizatio ...... y. A six-year follow-up study.
@nl
prefLabel
Prevention of new sensitizatio ...... y. A six-year follow-up study.
@en
Prevention of new sensitizatio ...... y. A six-year follow-up study.
@nl
P2093
P2860
P1476
Prevention of new sensitizatio ...... y. A six-year follow-up study.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2222.2001.01161.X
P577
2001-09-01T00:00:00Z